Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Effect of fatty acids on macrophage (wild type versus knockout) lipid levels (Study ST000684)

C18 POSITIVE ION MODE (Analysis AN001055)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10
PC 48:6; [M+H]+@8.68	ME190799	3.98	0.14	0.20	0.40	0.23	3.55	0.27	0.26	0.67	0.29
PC 24:0; [M+Na]+@3.68	ME190791	4.00	0.34	0.40	0.77	0.25	2.71	0.27	0.18	0.62	0.45
lysoPC 24:0; [M+H]+@5.05	ME190952	3.57	0.26	0.22	1.06	0.16	2.62	0.22	0.22	1.48	0.20
lysoPC 26:1; [M+H]+@5.05	ME190954	3.75	0.21	0.35	0.85	0.20	3.01	0.22	0.24	0.94	0.22
PC 46:6; [M+H]+@8.23	ME190798	3.90	0.24	0.13	1.08	0.19	2.91	0.15	0.15	1.10	0.14
lysoPC 24:1; [M+H]+@4.23	ME190953	2.65	0.34	0.34	1.77	0.17	2.49	0.18	0.20	1.74	0.11
DG 40:0; [M+NH4]+@9.59	ME190778	2.91	0.33	0.56	0.69	0.53	2.39	0.50	0.64	0.98	0.48
DG 42:0; [M+NH4]+@9.92	ME190785	2.19	0.36	0.66	0.60	1.12	2.39	0.34	0.65	0.83	0.89
CE(22:5); [M+NH4]+@10.65	ME190745	0.27	0.35	0.39	3.51	0.21	0.42	0.26	0.36	3.85	0.37
Unknown_824.7747_[M+NH4]+@9.71	ME190937	1.23	1.32	0.30	1.72	0.17	1.02	0.68	0.28	3.13	0.15
lysoPC 18:0; [M+H]+@2.33	ME190943	2.02	0.46	0.45	1.94	0.24	1.80	0.36	0.41	1.99	0.32
lysoPC 20:0; [M+H]+@3.24	ME190948	1.68	0.48	0.39	2.11	0.17	1.66	0.34	0.34	2.50	0.33
PE 36:1; [M+H]+@7.35	ME190817	1.66	0.84	0.21	2.18	0.13	2.00	0.71	0.19	1.92	0.15
SM 40:0; [M]+@7.84	ME190854	1.39	0.74	0.13	2.94	0.08	1.60	0.60	0.12	2.32	0.08
SM 41:1; [M]+@7.85	ME190858	1.40	0.68	0.15	2.77	0.09	1.53	0.55	0.13	2.59	0.11
SM 36:1; [M]+@6.39	ME190845	1.39	0.96	0.17	2.79	0.09	1.51	0.81	0.16	2.05	0.09
PE 40:2; [M+H]+@7.95	ME190829	1.34	0.93	0.10	2.56	0.06	1.78	0.71	0.09	2.34	0.09
plasmenyl-PE 38:3; [M+H]+@7.48	ME190973	1.58	0.80	0.14	2.67	0.08	1.76	0.64	0.12	2.13	0.09
PE 38:3; [M+H]+@7.15	ME190823	1.68	0.90	0.14	2.50	0.06	1.87	0.69	0.12	1.98	0.07
PE 40:4; [M+H]+@7.34	ME190830	1.77	0.82	0.14	2.55	0.07	1.75	0.67	0.11	2.07	0.06
DG 32:2; [M+NH4]+@6.96	ME190752	0.13	1.91	1.81	0.07	0.35	0.11	2.74	2.36	0.11	0.42
TG 49:2; [M+NH4]+@10.25	ME190882	0.09	2.06	2.01	0.08	0.16	0.06	2.58	2.69	0.08	0.19
TG 46:2; [M+NH4]+@9.80	ME190874	0.13	2.65	1.49	0.11	0.23	0.06	2.96	1.98	0.11	0.27
TG 51:3; [M+NH4]+@10.28	ME190892	0.13	2.43	1.80	0.18	0.28	0.10	2.55	1.93	0.20	0.39
DG 31:1; [M+NH4]+@7.16	ME190749	0.46	2.00	1.47	0.37	0.24	0.28	2.61	2.00	0.32	0.25
TG 54:8; [M+NH4]+@9.75	ME190913	0.18	2.38	1.36	0.27	0.33	0.42	2.28	1.84	0.51	0.43
PE 32:1; [M+H]+@6.13	ME190807	1.02	2.67	0.35	0.97	0.09	1.15	2.48	0.35	0.84	0.08
PC 32:2; [M+H]+@5.38	ME190794	0.61	3.15	0.67	0.58	0.12	0.69	2.67	0.53	0.78	0.18
PE 30:1; [M+H]+@5.48	ME190803	0.75	2.72	0.86	0.38	0.27	0.72	2.61	0.89	0.42	0.36
TG 48:3; [M+NH4]+@9.85	ME190879	0.07	3.08	1.07	0.08	0.18	0.04	3.65	1.57	0.08	0.20
TG 46:3; [M+NH4]+@9.57	ME190875	0.22	2.77	1.39	0.22	0.28	0.11	2.91	1.35	0.27	0.48
TG 49:3; [M+NH4]+@9.99	ME190883	0.19	2.75	1.35	0.18	0.20	0.10	3.33	1.49	0.16	0.26
PE 31:1; [M+H]+@5.84	ME190805	0.36	3.31	0.71	0.24	0.15	0.40	3.25	0.93	0.44	0.21
PE 32:2; [M+H]+@5.64	ME190808	0.31	3.75	0.60	0.14	0.09	0.30	3.81	0.69	0.20	0.12
CE(20:5); [M+NH4]+@10.36	ME190744	0.27	0.26	0.74	1.76	0.98	0.17	0.28	3.25	1.77	0.51
DG 31:0; [M+NH4]+@7.58	ME190748	0.93	1.29	1.54	0.46	0.63	0.68	1.33	1.94	0.54	0.66
DG 33:0; [M+NH4]+@8.03	ME190753	1.14	1.29	1.46	0.46	0.73	0.85	1.18	1.65	0.57	0.66
PE 34:2; [M+H]+@6.28	ME190812	0.74	1.64	1.21	0.34	1.01	0.76	1.49	1.20	0.39	1.23
PE 38:7; [M+H]+@5.68	ME190827	0.56	1.84	1.04	0.76	0.82	0.76	1.68	0.81	0.85	0.88
TG 52:2; [M+NH4]+@10.58	ME190896	0.47	1.67	1.26	0.68	0.86	0.56	1.64	1.15	0.81	0.90
PE 31:0; [M+H]+@6.36	ME190804	0.90	2.08	0.85	0.88	0.38	0.85	1.76	1.01	0.82	0.48
lysoPC 16:1; [M+H]+@1.20	ME190942	0.95	1.81	1.30	0.47	0.54	1.02	1.46	1.09	0.58	0.77
PE 35:4; [M+H]+@6.01	ME190816	0.96	1.26	1.37	0.95	0.69	1.01	1.65	0.96	0.61	0.55
PE 37:5; [M+H]+@6.12	ME190821	0.98	1.66	1.07	0.69	0.71	0.87	1.88	0.90	0.66	0.59
PE 31:2; [M+H]+@5.29	ME190806	1.29	1.80	0.76	0.37	0.67	0.65	2.40	1.23	0.49	0.33
TG 44:2; [M+NH4]+@9.51	ME190871	0.81	1.87	1.22	0.47	0.40	0.36	2.26	1.25	0.75	0.61
PE 33:1; [M+H]+@6.46	ME190810	0.35	2.16	1.33	0.28	0.81	0.34	2.08	1.60	0.31	0.74
PE 35:2; [M+H]+@6.59	ME190814	0.56	1.76	1.24	0.36	0.76	0.47	2.23	1.49	0.35	0.78
plasmenyl-PE 31:0; [M+H]+@6.68	ME190966	1.91	1.86	0.48	1.00	0.43	1.59	1.02	0.62	0.73	0.36
PE 36:2; [M+H]+@6.87	ME190818	1.46	1.03	0.36	1.80	0.39	1.80	0.89	0.37	1.53	0.38
PC 26:1; [M+Na]+@3.85	ME190792	2.19	0.89	0.69	0.89	0.37	1.58	0.35	0.87	1.66	0.51
PC 40:10; [M+H]+@5.40	ME190797	1.79	0.78	1.01	1.32	0.46	1.04	0.72	0.91	1.46	0.51
SM 32:2; [M+Na]+@4.44	ME190838	1.46	0.77	0.79	1.38	0.61	1.03	0.68	0.85	1.84	0.59
SM 33:2; [M]+@4.93	ME190840	1.40	0.97	0.64	1.45	0.56	1.12	0.75	0.64	1.78	0.69
lysoPC 15:0; [M+H]+@1.30	ME190940	1.39	1.36	0.69	1.11	0.45	1.42	0.96	0.65	1.33	0.64
PE 35:3; [M+H]+@6.15	ME190815	1.28	1.19	0.71	1.41	0.53	1.41	0.91	0.80	1.09	0.67
plasmenyl-PE 30:0; [M+H]+@6.39	ME190965	1.81	1.01	0.55	0.93	0.33	1.70	1.04	0.85	1.00	0.77
lysoPC 14:0; [M+H]+@1.03	ME190939	1.36	1.10	0.82	0.96	0.58	1.90	0.72	0.53	1.32	0.72
PE 42:6; [M+H]+@6.95	ME190833	1.41	0.99	0.63	1.00	0.87	1.55	0.69	0.63	1.28	0.95
plasmenyl-PE 34:0; [M+H]+@7.55	ME190967	1.74	0.84	0.84	1.12	0.55	1.70	0.57	0.75	1.26	0.65
SM 44:1; [M]+@8.60	ME190866	1.88	0.71	0.58	0.96	0.74	1.69	0.64	0.69	1.10	1.02
lysoPC 22:6; [M+Na]+@1.19	ME190951	0.75	0.52	1.06	0.70	1.07	1.27	0.41	0.56	1.26	2.39
lysoPC 18:2; [M+H]+@1.29	ME190945	1.13	0.55	0.80	0.59	1.54	1.48	0.36	0.71	0.70	2.13
lysoPE 18:2; [M+H]+@1.34	ME190959	0.78	0.65	0.93	0.54	1.67	1.01	0.46	0.91	0.73	2.31
PE 36:4; [M+H]+@6.33	ME190819	1.07	0.73	1.03	0.37	1.79	0.96	0.64	1.03	0.43	1.95
lysoPE 16:0; [M+H]+@1.66	ME190955	0.89	0.66	0.96	0.33	2.08	0.85	0.61	1.00	0.38	2.25
plasmenyl-PE 36:1; [M+H]+@7.61	ME190969	0.93	0.62	0.84	0.50	1.96	0.96	0.55	1.03	0.54	2.06
lysoPC 18:3; [M+H]+@1.09	ME190946	1.02	0.31	1.10	1.42	0.70	1.14	1.54	0.42	1.35	1.01
DG 30:0; [M+NH4]+@7.31	ME190746	1.02	0.86	1.41	0.28	1.25	0.90	0.83	1.53	0.34	1.57
TG 58:1; [M+NH4]+@11.55	ME190923	0.94	0.88	1.05	0.43	1.35	1.18	0.60	1.67	0.55	1.34
DG 38:4; [M+NH4]+@7.96	ME190774	0.59	0.88	1.47	0.99	0.95	0.50	0.85	1.55	1.12	1.10
DG 37:1; [M+NH4]+@8.68	ME190769	0.62	0.93	1.46	0.57	0.96	0.79	1.06	1.33	0.87	1.40
DG 42:4; [M+NH4]+@8.76	ME190786	0.76	0.73	1.30	0.76	1.24	0.76	0.77	1.29	1.03	1.37
DG 38:3; [M+NH4]+@8.29	ME190773	0.80	0.69	1.39	0.67	1.24	0.64	0.63	1.58	0.78	1.57
DG 40:4; [M+NH4]+@8.37	ME190780	0.69	0.79	1.48	0.66	1.25	0.56	0.73	1.63	0.80	1.41
SM 36:0; [M]+@6.70	ME190844	1.07	1.01	1.08	0.77	1.15	0.77	0.81	1.25	0.77	1.32
lysoPE 17:0; [M+H]+@2.02	ME190956	1.06	0.99	0.89	0.79	1.01	1.06	0.95	1.05	0.91	1.29
SM 34:1; [M]+@5.72	ME190841	1.03	0.94	0.99	0.82	1.19	0.93	0.93	1.07	0.86	1.24
PE 38:6; [M+H]+@6.23	ME190826	0.79	0.94	1.11	0.72	1.28	0.86	0.83	1.11	0.80	1.56
TG 53:0; [M+NH4]+@11.14	ME190901	0.81	0.93	1.22	0.79	1.31	0.82	0.93	1.11	0.79	1.29
PE 38:4; [M+H]+@6.86	ME190824	0.80	1.06	1.08	0.62	1.36	0.83	1.06	1.15	0.66	1.37
plasmenyl-PE 36:4; [M+H]+@6.60	ME190972	0.68	1.21	1.15	0.72	1.21	0.73	1.18	1.20	0.70	1.23
SM 38:2; [M]+@6.53	ME190850	0.64	1.27	0.82	0.73	1.28	0.58	1.16	1.10	0.88	1.53
SM 39:2; [M]+@6.82	ME190853	0.72	1.08	0.77	0.91	1.18	0.99	1.27	1.06	0.92	1.11
TG 54:3; [M+NH4]+@10.63	ME190908	0.52	1.20	1.10	0.96	1.13	0.70	1.17	1.07	1.03	1.14
DG 36:2; [M+NH4]+@8.02	ME190764	0.55	0.65	1.14	0.91	1.70	0.61	0.63	1.30	0.93	1.58
PE 38:5; [M+H]+@6.42	ME190825	0.95	0.92	1.01	0.51	1.61	0.87	0.83	0.99	0.58	1.72
PE 34:4; [M+H]+@5.66	ME190813	0.84	1.02	0.99	0.39	1.61	0.94	0.93	1.20	0.46	1.62
plasmenyl-PE 36:3; [M+H]+@6.89	ME190971	0.73	1.00	1.08	0.58	1.52	0.82	0.96	1.11	0.59	1.62
SM 41:2; [M]+@7.33	ME190859	0.51	0.98	1.05	0.63	1.41	0.61	1.00	1.14	0.74	1.91
SM 38:1; [M]+@7.12	ME190849	0.56	0.95	1.01	0.67	1.50	0.63	1.06	1.19	0.74	1.69
SM 42:4; [M]+@6.79	ME190862	0.60	1.03	1.12	0.61	1.52	0.55	1.01	1.30	0.67	1.59
PE 19:1; [M+H]+@1.86	ME190800	0.81	0.76	1.00	0.58	1.65	0.68	0.85	1.24	0.76	1.67
MG 17:0; [M+Li]+@3.19	ME190788	0.57	0.98	1.17	0.55	1.81	0.57	0.89	1.26	0.55	1.65
PC 32:0; [M+H]+@6.41	ME190793	0.64	0.82	1.13	0.58	1.81	0.66	0.79	1.24	0.57	1.75
DG 35:0; [M+NH4]+@8.50	ME190759	1.44	1.18	1.23	0.63	0.64	1.37	0.74	1.20	0.65	0.92
DG 34:0; [M+NH4]+@8.35	ME190756	1.65	0.79	1.17	0.55	0.89	1.31	0.68	1.10	0.65	1.21
DG 38:0; [M+NH4]+@9.23	ME190771	1.68	0.67	1.10	0.59	0.80	1.46	0.74	1.06	0.96	0.95
DG 40:1; [M+NH4]+@9.24	ME190779	1.46	0.64	1.11	0.67	0.90	1.65	0.54	1.12	0.84	1.07
SM 38:4; [M]+@5.56	ME190851	1.42	0.53	0.66	0.55	1.37	1.09	0.92	0.91	1.39	1.16
lysoPC 16:0; [M+H]+@1.56	ME190941	1.44	0.61	0.91	0.67	1.30	1.48	0.49	0.83	0.74	1.52
lysoPE 18:0; [M+H]+@2.45	ME190957	1.29	0.88	0.95	0.70	1.25	1.21	0.70	0.90	0.74	1.39
plasmenyl-PE 36:2; [M+H]+@7.25	ME190970	1.01	0.88	0.90	0.64	1.37	1.06	0.74	0.92	0.80	1.67
DG 36:0; [M+NH4]+@8.83	ME190762	0.79	0.97	0.78	0.98	0.64	0.91	1.11	1.56	1.61	0.63
TG 42:1; [M+NH4]+@9.48	ME190869	1.30	1.19	1.44	0.88	0.68	0.54	0.99	1.22	1.13	0.63
PE 33:0; [M+H]+@6.88	ME190809	1.19	1.25	0.99	0.89	0.73	0.85	1.19	1.23	0.86	0.83
PE 21:4; [M+H]+@1.33	ME190801	0.83	1.30	1.01	1.05	0.85	0.87	1.18	1.08	1.04	0.78
SM 37:1; [M]+@6.78	ME190846	1.00	1.17	0.87	0.97	0.87	0.94	1.24	1.12	0.97	0.84
SM 30:1; [M]+@4.26	ME190834	0.71	1.21	0.83	1.33	0.57	1.12	0.74	0.85	1.78	0.87
PE 23:4; [M+H]+@1.92	ME190802	0.92	1.20	0.77	1.27	0.66	0.98	1.01	0.87	1.57	0.75
SM 42:5; [M]+@6.49	ME190863	0.90	1.16	0.69	1.44	0.67	0.93	0.86	1.09	1.43	0.83
lysoPC 19:0; [M+H]+@2.75	ME190947	1.05	0.83	0.91	1.43	0.85	0.92	0.88	0.87	1.47	0.78
SM 35:2; [M]+@5.61	ME190843	0.81	0.97	0.85	1.46	0.80	0.71	0.89	1.01	1.55	0.94
SM 33:1; [M+Na]+@5.41	ME190839	1.59	0.64	0.85	1.12	0.92	1.31	0.64	0.86	0.94	1.12
PC 38:7; [M+H]+@6.13	ME190796	1.12	0.66	1.01	1.29	1.06	1.07	0.65	0.97	1.06	1.12
SM 41:0; [M]+@8.10	ME190857	0.79	0.84	0.90	0.93	1.12	1.14	0.75	0.97	1.14	1.41
SM 34:2; [M+Na]+@5.22	ME190842	0.98	0.73	0.85	1.02	1.34	0.89	0.84	1.07	1.07	1.21
PE 40:7; [M+H]+@6.33	ME190831	0.90	0.92	0.85	1.07	1.23	0.81	0.96	0.92	1.03	1.31
SM 38:0; [M]+@7.29	ME190848	0.99	0.82	0.86	0.99	1.17	0.87	0.82	0.93	1.23	1.31
PE 38:1; [M+H]+@7.82	ME190822	1.11	0.95	0.78	0.96	0.88	1.24	0.80	0.64	1.14	1.49
PE 42:3; [M+H]+@8.01	ME190832	1.23	0.82	0.81	1.01	1.15	1.11	0.72	0.73	1.01	1.42
PE 37:3; [M+H]+@6.89	ME190820	1.14	1.10	0.99	0.97	0.78	1.18	0.94	0.94	1.04	0.90
plasmenyl-PE 38:6; [M+H]+@6.51	ME190975	1.08	1.07	0.96	1.02	0.83	1.12	0.98	0.91	1.12	0.92
SM 40:4; [M]+@6.13	ME190856	1.22	1.05	0.87	1.01	0.98	0.93	0.80	0.91	1.17	1.07
plasmenyl-PE 38:4; [M+H]+@7.15	ME190974	0.97	1.02	0.97	1.02	0.93	0.99	0.97	0.92	1.16	1.05
SM 40:1; [M]+@7.54	ME190855	1.05	0.95	0.84	1.02	1.01	1.04	0.98	0.93	1.08	1.10
plasmenyl-PE 40:5; [M+H]+@7.29	ME190976	1.10	0.96	0.74	1.26	0.81	1.04	0.79	0.68	1.65	0.99
SM 44:2; [M]+@8.13	ME190867	1.30	0.86	0.68	1.24	0.81	1.19	0.70	0.65	1.50	1.07
lysoPC 20:1; [M+H]+@2.48	ME190949	1.00	0.89	0.75	1.19	0.94	1.14	0.62	0.60	1.39	1.47
SM 43:2; [M]+@7.81	ME190865	0.94	0.92	0.84	1.09	0.84	1.09	0.80	0.88	1.39	1.20
SM 39:1; [M]+@7.35	ME190852	1.04	0.87	0.85	1.10	0.87	1.10	0.78	0.76	1.34	1.28
SM 42:2; [M]+@7.58	ME190861	1.06	0.93	0.84	1.12	0.91	1.09	0.78	0.76	1.30	1.20
SM 32:1; [M+Na]+@5.06	ME190837	1.15	0.86	0.75	1.29	0.83	1.01	0.76	1.02	1.23	1.09
PE 40:1; [M+H]+@8.32	ME190828	1.40	0.91	0.73	1.05	0.88	1.12	0.75	0.87	1.27	1.04
SM 42:1; [M]+@8.09	ME190860	1.27	0.90	0.75	1.07	0.89	1.28	0.72	0.80	1.22	1.10
SM 43:1; [M]+@8.39	ME190864	1.20	0.87	0.70	0.96	0.93	1.26	0.75	0.86	1.30	1.16
lysoPC 20:5; [M+H]+@1.08	ME190950	0.68	0.71	1.05	0.93	1.51	1.12	0.49	0.59	1.23	1.68
PC 21:1; [M+H]+@1.96	ME190790	0.46	0.99	0.93	1.00	1.75	0.49	0.63	0.67	1.52	1.56
SM 32:0; [M]+@5.36	ME190836	0.88	0.74	0.94	1.28	0.99	0.82	0.73	0.93	1.49	1.21
lysoPE 22:4; [M+H]+@1.75	ME190962	0.68	0.93	0.86	1.11	1.19	0.71	0.73	0.90	1.64	1.26
lysoPE 20:4; [M+H]+@1.28	ME190961	0.60	0.87	0.96	1.03	1.28	0.64	0.67	0.90	1.61	1.45
lysoPE 22:5; [M+H]+@1.40	ME190963	0.67	0.89	0.88	0.96	1.21	0.69	0.78	0.96	1.58	1.38
DG 35:2; [M+NH4]+@7.79	ME190761	0.70	1.99	0.75	1.23	0.07	0.80	1.88	0.92	1.58	0.08
TG 56:4; [M+NH4]+@10.76	ME190917	0.47	1.84	0.82	1.72	0.33	0.64	1.53	0.73	1.58	0.35
TG 58:5; [M+NH4]+@10.78	ME190928	0.37	2.00	0.60	1.86	0.28	0.47	1.74	0.58	1.80	0.30
CE(18:1); [M+NH4]+@10.96	ME190743	0.49	0.50	0.79	2.07	0.90	0.36	0.31	0.94	2.72	0.93
SM 31:1; [M]+@4.68	ME190835	0.86	0.92	0.75	1.93	0.59	0.74	0.85	0.76	2.04	0.58
DG 34:2; [M+NH4]+@7.50	ME190757	0.17	0.99	2.39	0.10	0.68	0.16	1.18	3.41	0.13	0.79
TG 49:1; [M+NH4]+@10.45	ME190881	0.08	0.95	2.66	0.05	0.82	0.06	1.14	3.41	0.06	0.77
DG 33:1; [M+NH4]+@7.70	ME190754	0.19	1.16	2.32	0.11	0.78	0.14	1.34	2.92	0.18	0.85
DG 38:7; [M+NH4]+@6.95	ME190777	0.09	1.17	2.35	0.18	0.57	0.14	1.47	3.10	0.10	0.83
TG 51:2; [M+NH4]+@10.50	ME190891	0.07	1.32	2.58	0.07	0.61	0.06	1.55	3.02	0.09	0.63
TG 51:4; [M+NH4]+@10.09	ME190893	0.13	1.30	2.36	0.13	0.61	0.09	1.67	2.89	0.19	0.63
TG 53:5; [M+NH4]+@10.13	ME190905	0.04	1.48	2.34	0.15	0.65	0.07	1.62	2.77	0.16	0.72
TG 49:0; [M+NH4]+@10.68	ME190880	0.12	0.86	2.18	0.07	1.47	0.15	0.95	3.22	0.10	0.87
TG 46:1; [M+NH4]+@10.04	ME190873	0.07	1.18	2.31	0.05	0.98	0.07	1.26	2.93	0.06	1.10
TG 51:1; [M+NH4]+@10.71	ME190890	0.14	1.12	2.20	0.10	1.04	0.16	1.17	2.90	0.15	1.02
DG 36:5; [M+NH4]+@7.00	ME190767	0.15	1.04	2.25	0.21	1.12	0.08	1.02	2.72	0.21	1.20
DG 32:1; [M+NH4]+@7.39	ME190751	0.11	0.91	2.12	0.06	1.29	0.12	1.12	2.72	0.07	1.47
TG 52:5; [M+NH4]+@10.08	ME190899	0.06	1.00	2.33	0.09	1.17	0.07	1.13	2.65	0.10	1.41
DG 34:3; [M+NH4]+@7.18	ME190758	0.16	0.84	2.08	0.20	1.22	0.14	1.19	2.41	0.28	1.46
TG 50:2; [M+NH4]+@10.32	ME190886	0.07	1.02	2.06	0.05	1.48	0.08	1.09	2.52	0.07	1.56
TG 53:2; [M+NH4]+@10.73	ME190902	0.12	1.06	1.93	0.15	1.26	0.15	1.11	2.55	0.18	1.49
DG 37:5; [M+NH4]+@7.34	ME190770	0.35	1.36	2.46	0.50	0.52	0.38	1.31	1.92	0.59	0.61
TG 56:9; [M+NH4]+@9.82	ME190922	0.12	1.89	1.73	0.72	0.56	0.17	1.48	1.92	0.70	0.71
DG 33:2; [M+NH4]+@7.27	ME190755	0.27	1.71	1.92	0.30	0.39	0.33	1.94	2.40	0.45	0.29
TG 53:3; [M+NH4]+@10.53	ME190903	0.13	1.45	2.31	0.14	0.52	0.14	1.88	2.51	0.22	0.69
TG 44:1; [M+NH4]+@9.79	ME190870	0.28	1.63	1.98	0.20	0.57	0.16	1.71	2.59	0.21	0.67
TG 50:5; [M+NH4]+@9.73	ME190889	0.17	1.60	1.87	0.18	0.65	0.14	1.78	2.46	0.30	0.85
TG 48:2; [M+NH4]+@10.09	ME190878	0.05	1.82	2.04	0.04	0.54	0.05	2.03	2.76	0.06	0.60
TG 50:3; [M+NH4]+@10.13	ME190887	0.08	1.85	1.91	0.08	0.55	0.07	2.11	2.63	0.10	0.63
DG 30:1; [M+NH4]+@6.85	ME190747	0.18	1.60	1.99	0.13	0.65	0.21	2.07	2.27	0.15	0.75
TG 55:6; [M+NH4]+@10.25	ME190915	0.12	1.84	1.75	0.23	0.57	0.09	2.11	2.36	0.30	0.63
TG 55:4; [M+NH4]+@10.63	ME190914	0.12	1.36	2.29	0.33	1.13	0.10	1.23	1.79	0.44	1.21
TG 53:4; [M+NH4]+@10.42	ME190904	0.09	1.52	2.15	0.15	0.80	0.11	1.49	2.48	0.48	0.73
TG 54:7; [M+NH4]+@10.00	ME190912	0.07	1.54	2.31	0.16	0.75	0.06	1.47	2.36	0.19	1.08
TG 50:4; [M+NH4]+@9.94	ME190888	0.14	1.71	1.86	0.16	0.86	0.14	1.60	2.20	0.21	1.12
TG 52:6; [M+NH4]+@9.85	ME190900	0.05	1.34	2.02	0.14	0.99	0.06	1.46	2.33	0.18	1.44
TG 56:8; [M+NH4]+@10.07	ME190921	0.06	1.41	1.90	0.27	1.01	0.08	1.47	2.19	0.33	1.28
Unknown_862.7904_[M+NH4]+@9.84	ME190938	0.09	0.86	0.63	0.18	2.49	0.18	1.61	1.77	0.11	2.08
DG 40:7; [M+NH4]+@7.51	ME190783	0.04	0.22	1.57	0.10	2.76	0.05	0.25	1.76	0.12	3.11
MG 16:0; [M+Li]+@2.50	ME190787	0.09	0.36	1.32	0.09	3.12	0.08	0.41	1.44	0.09	3.01
PE 34:1; [M+H]+@6.75	ME190811	0.19	0.57	1.12	0.12	2.87	0.21	0.57	1.42	0.13	2.80
DG 32:0; [M+NH4]+@7.83	ME190750	0.71	0.39	1.36	0.13	2.36	0.64	0.40	1.48	0.16	2.37
MG 18:1; [M+Li]+@2.77	ME190789	0.48	0.48	1.30	0.27	2.54	0.31	0.38	1.50	0.18	2.55
lysoPE 20:3; [M+Na]+@2.48	ME190960	0.72	0.60	0.94	0.49	2.20	0.62	0.43	0.91	0.41	2.66
plasmenyl-PE 34:1; [M+H]+@7.05	ME190968	0.46	0.62	1.05	0.37	2.23	0.54	0.64	1.17	0.43	2.48
PC 36:2; [M+H]+@6.67	ME190795	0.35	0.41	1.05	0.37	2.84	0.41	0.40	1.22	0.40	2.56
plasmenyl-PC 18:0; [M+Na]+@1.64	ME190964	0.32	0.41	1.02	0.36	2.69	0.43	0.30	0.97	0.49	3.03
lysoPC 18:1; [M+H]+@1.85	ME190944	0.48	0.46	0.96	0.41	2.53	0.55	0.33	0.94	0.46	2.90
lysoPE 18:1; [M+H]+@1.78	ME190958	0.49	0.55	0.96	0.29	2.61	0.58	0.42	1.02	0.37	2.70
DG 40:6; [M+NH4]+@7.79	ME190782	0.16	0.32	3.09	0.17	1.19	0.15	0.29	2.10	0.24	2.28
SM 37:2; [M]+@6.30	ME190847	0.34	0.74	2.81	0.51	0.82	0.43	0.77	1.63	0.43	1.52
TG 60:11; [M+NH4]+@10.02	ME190933	0.09	1.14	1.75	1.00	1.05	0.14	0.90	1.49	1.07	1.37
TG 60:12; [M+NH4]+@9.89	ME190934	0.10	1.08	1.55	0.97	1.05	0.06	1.01	1.78	1.06	1.34
TG 58:6; [M+NH4]+@10.62	ME190929	0.14	1.43	1.59	0.53	1.08	0.16	1.31	1.69	0.65	1.43
TG 60:9; [M+NH4]+@10.34	ME190936	0.06	1.35	1.36	0.81	1.46	0.09	1.36	1.29	0.87	1.36
TG 46:0; [M+NH4]+@10.27	ME190872	0.07	0.31	2.15	0.02	2.13	0.07	0.31	2.30	0.03	2.61
TG 48:0; [M+NH4]+@10.58	ME190876	0.13	0.38	2.27	0.02	1.63	0.10	0.35	2.79	0.04	2.29
TG 50:0; [M+NH4]+@10.78	ME190884	0.34	0.62	1.50	0.11	2.56	0.37	0.65	2.31	0.16	1.38
DG 38:5; [M+NH4]+@7.55	ME190775	0.32	0.61	1.92	0.34	1.60	0.26	0.61	2.27	0.40	1.67
DG 40:8; [M+NH4]+@7.11	ME190784	0.39	0.59	2.19	0.36	1.53	0.31	0.57	2.23	0.31	1.51
TG 54:4; [M+NH4]+@10.48	ME190909	0.11	0.75	1.96	0.15	1.82	0.14	0.82	2.06	0.17	2.00
TG 48:1; [M+NH4]+@10.29	ME190877	0.07	0.94	2.12	0.03	1.71	0.09	0.97	2.26	0.06	1.75
TG 52:3; [M+NH4]+@10.37	ME190897	0.09	0.78	1.99	0.08	1.71	0.10	0.91	2.39	0.10	1.85
TG 52:4; [M+NH4]+@10.22	ME190898	0.12	0.73	2.02	0.12	1.79	0.16	0.77	2.31	0.13	1.86
DG 35:1; [M+NH4]+@8.17	ME190760	0.61	1.19	1.65	0.44	0.96	0.42	1.14	1.91	0.57	1.12
DG 36:6; [M+NH4]+@6.83	ME190768	0.49	0.89	1.76	0.39	1.15	0.35	1.17	2.02	0.41	1.38
DG 36:4; [M+NH4]+@7.48	ME190766	0.50	0.67	1.88	0.42	1.22	0.53	0.66	2.07	0.56	1.48
TG 42:0; [M+NH4]+@9.77	ME190868	0.58	0.87	1.72	0.39	1.38	0.47	0.85	1.85	0.47	1.42
TG 58:2; [M+NH4]+@11.30	ME190925	0.43	0.97	1.59	0.32	1.37	0.57	0.73	1.82	0.50	1.72
TG 58:9; [M+NH4]+@10.14	ME190932	0.08	1.07	1.94	0.49	1.27	0.10	0.90	2.00	0.60	1.56
TG 56:5; [M+NH4]+@10.57	ME190918	0.12	1.20	1.78	0.30	1.31	0.14	1.17	1.98	0.41	1.58
TG 58:10; [M+NH4]+@9.93	ME190924	0.04	1.07	1.85	0.32	1.51	0.06	1.04	2.08	0.33	1.71
DG 40:5; [M+NH4]+@8.01	ME190781	0.33	0.72	1.66	0.46	1.61	0.32	0.73	1.86	0.58	1.72
TG 58:4; [M+NH4]+@10.94	ME190927	0.16	0.89	1.72	0.32	1.62	0.24	0.87	2.02	0.43	1.74
TG 58:3; [M+NH4]+@11.16	ME190926	0.21	0.85	1.87	0.33	1.40	0.26	1.11	1.79	0.42	1.75
TG 60:4; [M+NH4]+@11.15	ME190935	0.18	0.75	1.94	0.45	1.35	0.38	0.85	2.02	0.43	1.65
TG 54:5; [M+NH4]+@10.31	ME190910	0.06	0.66	1.87	0.10	2.11	0.08	0.72	1.92	0.11	2.37
TG 56:6; [M+NH4]+@10.37	ME190919	0.06	0.72	1.63	0.15	2.24	0.07	0.77	1.78	0.18	2.41
TG 56:7; [M+NH4]+@10.22	ME190920	0.04	0.73	1.67	0.16	2.16	0.05	0.74	1.83	0.17	2.44
TG 52:1; [M+NH4]+@10.79	ME190895	0.12	0.51	1.77	0.07	2.26	0.16	0.56	2.16	0.11	2.27
TG 50:1; [M+NH4]+@10.54	ME190885	0.11	0.68	1.94	0.05	1.92	0.13	0.69	2.06	0.08	2.34
TG 54:6; [M+NH4]+@10.20	ME190911	0.04	0.65	1.90	0.06	1.98	0.04	0.73	2.25	0.08	2.26
TG 52:0; [M+NH4]+@11.03	ME190894	0.19	0.50	1.40	0.11	2.66	0.23	0.55	1.89	0.15	2.33
TG 54:2; [M+NH4]+@10.83	ME190907	0.11	0.47	1.62	0.08	2.39	0.13	0.49	1.85	0.13	2.74
DG 38:2; [M+NH4]+@8.51	ME190772	0.59	0.66	1.44	0.33	1.45	0.62	0.75	1.59	0.55	2.03
DG 38:6; [M+NH4]+@7.33	ME190776	0.32	0.47	1.79	0.26	1.80	0.35	0.44	2.00	0.33	2.24
TG 54:1; [M+NH4]+@11.05	ME190906	0.32	0.66	1.61	0.19	1.80	0.37	0.67	1.97	0.29	2.12
DG 36:1; [M+NH4]+@8.42	ME190763	0.58	0.56	1.48	0.28	1.84	0.53	0.54	1.79	0.33	2.07
DG 36:3; [M+NH4]+@7.70	ME190765	0.43	0.48	1.46	0.45	1.94	0.40	0.48	1.61	0.51	2.24
TG 58:8; [M+NH4]+@10.29	ME190931	0.10	0.81	1.43	0.52	2.01	0.10	0.62	1.14	0.63	2.64
TG 56:3; [M+NH4]+@10.88	ME190916	0.18	0.90	1.70	0.22	1.74	0.25	0.73	1.61	0.34	2.33
TG 58:7; [M+NH4]+@10.41	ME190930	0.09	0.88	1.43	0.35	2.10	0.10	0.86	1.56	0.40	2.23

Factors:

F1	genotype:rage knockout \| treatment:BSA
F2	genotype:rage knockout \| treatment:conditioned media with BSA
F3	genotype:rage knockout \| treatment:conditioned media with palm + oleate
F4	genotype:rage knockout \| treatment:none
F5	genotype:rage knockout \| treatment:palm + oleate
F6	genotype:wild type \| treatment:BSA
F7	genotype:wild type \| treatment:conditioned media with BSA
F8	genotype:wild type \| treatment:conditioned media with palm + oleate
F9	genotype:wild type \| treatment:none
F10	genotype:wild type \| treatment:palm + oleate

Data matrix